The current tariff environment underscores the importance of agility, adaptability, and strategic foresight in maintaining and enhancing competitive leadership.
Learn more about how current trade policies and tariffs on medical devices are shaking up U.S. medical device manufacturing.
Good news drives M&A activity and bad news is tolerable as long as it is understood, but uncertainty is the main nemesis of growth.
Factors contributing to manufacturing’s continuous evolution include reproducible, high-quality, AI-enabled technologies; higher product demand; and cost pressures.
MedWorld Advisors recently presented The DNA of Successful M&A Process, a webinar hosted by MPO. Weren’t able to attend? Click here to watch the recording so you too can learn how to strategically plan for M&A success, align objectives and long term goals, best practices, and more!
It will be exciting to watch this M&A resurgence continue to take shape through 2025 and beyond.
Whether through mergers and acquisitions or spinoffs, the spine sector looks significantly different than it did in 2020.
Asia has remained an industrial stalwart for its unique combination of cost efficiency, technological expertise, and scalability.
Ten years ago, finding orthopedic companies at CES was quite a surprise. Now, it’s more shocking to discover who’s missing.
When it comes to your business, value isn’t just about numbers. It’s about what lies beneath. Managing Director Dave Sheppard speaks to building intrinsic value in your medtech manufacturing business on the Moore on Manufacturing podcast.